Holmium laser enucleation of the prostate (HoLEP) has been shown in multiple studies to be the definitive surgery for benign prostatic hyperplasia (BPH). It is size independent, allows for maximum removal of prostate tissue, and has a retreatment rate of about 1% at two decades.